Cleveland Diagnostics

Cleveland Diagnostics, Inc. is a biotechnology company focused on developing innovative diagnostic tests for the early detection of diseases, particularly cancer. The company generates revenue by commercializing its proprietary diagnostic platform, which leverages technology to identify disease-specific biomarkers with high sensitivity and specificity. Founded in 2013, Cleveland Diagnostics has made significant strides in the field of cancer diagnostics, with its lead product, IsoPSA, designed to improve prostate cancer detection. The company is committed to advancing healthcare through cutting-edge diagnostic solutions that enhance patient outcomes and reduce healthcare costs.

Recent Posts by Cleveland Diagnostics

1-6 of 6